Literature DB >> 28101716

Circulating activated protein C in thrombophilia carriers.

Thijs E van Mens1, Joost C M Meijers2,3, Saskia Middeldorp4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28101716     DOI： 10.1007/s11239-016-1472-y

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  10 in total

1.  A monoclonal antibody against activated protein C allows rapid detection of activated protein C in plasma and reveals a calcium ion dependent epitope involved in factor Va inactivation.

Authors:  P C Y Liaw; G Ferrell; C T Esmon
Journal:  J Thromb Haemost       Date:  2003-04       Impact factor: 5.824

2.  Direct detection of activated protein C in blood from human subjects.

Authors:  A Gruber; J H Griffin
Journal:  Blood       Date:  1992-05-01       Impact factor: 22.113

3.  Inflammation-associated activation of coagulation and immune regulation by the protein C pathway.

Authors:  Hartmut Weiler
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

Review 4.  Activated protein C: biased for translation.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

Review 5.  Protein C inhibitor.

Authors:  Joost C M Meijers; Heiko Herwald
Journal:  Semin Thromb Hemost       Date:  2011-07-30       Impact factor: 4.180

6.  Monitoring of plasma levels of activated protein C using a clinically applicable oligonucleotide-based enzyme capture assay.

Authors:  J Müller; M Friedrich; T Becher; J Braunstein; T Kupper; P Berdel; S Gravius; F Rohrbach; J Oldenburg; G Mayer; B Pötzsch
Journal:  J Thromb Haemost       Date:  2012-03       Impact factor: 5.824

7.  Activation of the protein C pathway in hereditary thrombophilia.

Authors:  E M Faioni; F Franchi; D Asti; P M Mannucci
Journal:  Thromb Haemost       Date:  1998-10       Impact factor: 5.249

Review 8.  Evolution of Factor V Leiden.

Authors:  Thijs E van Mens; Marcel Levi; Saskia Middeldorp
Journal:  Thromb Haemost       Date:  2013-04-25       Impact factor: 5.249

9.  Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.

Authors:  Karin Strandberg; Peter J Svensson; Ann-Kristin Ohlin
Journal:  Thromb Res       Date:  2007-05-11       Impact factor: 3.944

10.  Circulating activated protein C in subjects with heterozygous Gln506-factor V.

Authors:  J Petäjä; L Hakala; V Rasi; J H Griffin
Journal:  Haemostasis       Date:  1998 Jan-Feb
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.